Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

FromNeurology® Podcast


Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

FromNeurology® Podcast

ratings:
Length:
24 minutes
Released:
Mar 28, 2024
Format:
Podcast episode

Description

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology and Neuroinflammation.  Disclosures can be found at Neurology.org.
Released:
Mar 28, 2024
Format:
Podcast episode

Titles in the series (100)

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Regular features also include Delayed Recall, ePearls, and What’s Trending. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Wednesday.